about
Point of use ultrasound by general surgeons: review of the literature and suggestions for future practiceSurgery in the era of the 'omics revolutionWhole-genome methylation analysis of benign and malignant colorectal tumoursDown-regulation of serum/glucocorticoid regulated kinase 1 in colorectal tumours is largely independent of promoter hypermethylation.Can the risk of obstetric anal sphincter injuries (OASIs) be predicted using a risk-scoring system?Outcome of repair of obstetric anal sphincter injuries after three years.Expression and DNA methylation of TNF, IFNG and FOXP3 in colorectal cancer and their prognostic significance.Loss of expression and promoter methylation of SLIT2 are associated with sessile serrated adenoma formation.Biomarker-based treatment selection in early-stage rectal cancer to promote organ preservation.Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres.Methylation changes in the TFAP2E promoter region are associated with BRAF mutation and poorer overall & disease free survival in colorectal cancer.Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder CancerCytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium.Pitfalls in the use of laparoscopic staplers to perform subtotal cholecystectomy.The genomics of colorectal cancer: state of the art.Epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma: a systematic review protocolRisk factors and management patterns for emergency obstetric hysterectomy over 2 decades.A systematic review of transarterial embolization versus emergency surgery in treatment of major nonvariceal upper gastrointestinal bleedingEndothelial protein C receptor is overexpressed in colorectal cancer as a result of amplification and hypomethylation of chromosome 20qAn immunogenomic stratification of colorectal cancer: Implications for development of targeted immunotherapy.BRAF mutations are associated with increased iron regulatory protein-2 expression in colorectal tumorigenesis.An unusual polyp at colonoscopy.Genomics and breast cancer: the different levels of inherited susceptibility.KRAS mutation and Consensus Molecular Subtypes 2 and 3 are independently associated with reduced immune infiltration and reactivity in colorectal cancer.Bleomycin-induced alveolitis detected by FDG positron emission tomography.Localization of parathyroid adenomas using 11C-methionine positron emission tomography.Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolution.Decidual T Cells Exhibit a Highly Differentiated Phenotype and Demonstrate Potential Fetal Specificity and a Strong Transcriptional Response to IFN.Whole Genome Methylation Analysis of Nondysplastic Barrett Esophagus that Progresses to Invasive Cancer.The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100.A pilot study of ultrasound guided Durasphere injection in the treatment of faecal incontinence.Nanopore sequencing and assembly of a human genome with ultra-long reads.Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response.Metabolic therapy with PEG-arginase induces a sustained complete remission in immunotherapy-resistant melanoma.Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinomaDisruption of CTCF-YY1-dependent looping of the human papillomavirus genome activates differentiation-induced viral oncogene transcriptionDiscovery and Validation of Methylation Biomarkers for Ulcerative Colitis Associated Neoplasia.The Safety and Tolerability of a Potential Alginate-Based Iron Chelator; Results of A Healthy Participant StudySubtype-specific regulatory network rewiring in acute myeloid leukemia.
P50
Q26825818-CD8B8EFA-9470-4331-AE77-D4E6D4840FA1Q26852061-75A24B83-7FE2-4F3D-AEE5-9877C4101187Q28109367-04E9595D-1D17-4A1D-BEE0-141D66F7FD65Q33747777-2D330CF6-DA00-4541-BEBC-7DFF23C850B5Q33990432-4962CB91-C9B1-42B4-A002-2F6BDF853D43Q34244377-62F4DCEC-35BC-4496-8F8A-FB5FC8B4D149Q34354653-70AA69E6-FF39-429B-A77F-D2ED1D3F9B96Q34720314-EA9A3470-AC4D-4C3B-A2CA-B744D8D4D876Q34803369-FABCBAED-7F4D-4C0B-910D-D829DE0BE3A3Q35561304-E7059094-8B43-40AF-94DE-7322624B322EQ35633533-9C7E081C-882B-4EB7-B57E-56483E359720Q35745033-83930204-DA2E-4CE7-8963-00C957B80DABQ35930911-84004C65-4A17-4409-8822-FC0F877F8B17Q36126324-3AF47030-221F-4245-9BBC-B5CB48846A2EQ36818765-7D2A1F84-8442-4E6E-B679-1F641E986539Q37172151-FCA8E672-5DB7-46CB-A90E-5EDF3603D990Q37517081-06E0DA2E-DF4B-4AA5-ACEF-8689DD215B95Q37642266-000E9FB3-64BC-4EAF-9D34-89AD5555D823Q37721837-0AD9723E-91CA-4DB7-AD4B-8253F1D45C25Q38695836-E3886D21-E05E-4A36-8A0A-CC808EB63D13Q39833507-A58B889D-378D-41D9-B4D1-26CD3F45327CQ41071955-E1BD3372-1093-4E64-AB6E-0C5802B96A70Q42258288-C4D5C3AD-C8CC-49BA-AE0C-BD5FE3B50349Q42353857-4F19B8D0-F32C-4A17-8D4D-C3D114ECB2C0Q42778262-64DA2B1B-9143-400E-9D47-C121FAA934ABQ44033766-1F31B133-2DD4-4078-83A7-CA86F46EB25AQ45229202-D1B76923-4A84-41D4-832C-E67E56570AB2Q47137439-39C3BD58-D4DD-4880-8CEF-29EC83915A62Q47684869-DB193529-8683-4F69-8349-5F4B6EB90F8FQ47702385-7C60EE6A-BDD9-472D-8928-2A2BE58B46B1Q48249089-C50582FB-07D9-444D-BE31-5D18B6BFAF79Q48431030-6E7B1A98-646A-4EA7-A569-9CE78B95AE51Q50066036-932D2DB2-4E59-4024-9968-6B2C5F533A78Q52336141-20C0678B-2D9A-41F7-96DD-FA8DDCEEBF50Q55260248-E0D51797-A676-496E-8C73-22345C41E357Q57178166-F9533F99-0987-43F5-AECB-55D9C99A6E85Q57788599-5B8F4446-46EE-458B-9A6E-C459BFDEC928Q60029836-4C525340-B630-4597-8D05-297097455744Q64067043-88CDD8F1-37B4-4890-B76A-F4EF0E446846Q64911185-1137D45F-119A-4820-AF4E-96AFEA3EDA2D
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-0784-2967
@en
name
Andrew Beggs
@ast
Andrew Beggs
@en
Andrew Beggs
@es
Andrew Beggs
@nl
type
label
Andrew Beggs
@ast
Andrew Beggs
@en
Andrew Beggs
@es
Andrew Beggs
@nl
altLabel
A D Beggs
@en
prefLabel
Andrew Beggs
@ast
Andrew Beggs
@en
Andrew Beggs
@es
Andrew Beggs
@nl
P106
P1153
24343181100
P31
P496
0000-0003-0784-2967